Europe's healthcare landscape is undergoing a structural shift driven by the 2026 EU HTA regulation updates. Effective healthcare market research Europe now requires a dual focus on centralized clinical assessments and local reimbursement nuances.
Healthcare Market Research Europe: Navigating the 2026 HTA Shift
By Mohammad Ashour
Category: Market Access
Frequently Asked Questions
What is the JCA?
The Joint Clinical Assessment is a unified clinical review for the EU, starting with oncology and ATMPs in 2026.